The latest information about the CellSearch™ Circulating Tumor Cell Test will be available via a live interactive web conference on Tuesday, Sept. 30 at 12 p.m. EST.
The webcast, titled “The CellSearch™ Circulating Tumor Cell (CTC) Test for Use in the Monitoring of Metastatic Breast Cancer Patients,” will last approximately one hour and consist of a 45-minute presentation followed by a question and answer session.
The speakers are Dr. Minetta Liu, assistant professor of medicine, division of hematology/oncology at Lombardi Cancer Center, and Dr. Alberto Montero, assistant professor of medicine at the University of Miami Sylvester Comprehensive Cancer Center.
Register online at www.123enroll.com/veridex or by calling 1-800-238-9620 PIN 5585. Follow instructions to register for this program. International registrants, please use online registration only. Once registered, you will receive an email confirmation that includes instructions for participating.
Please be advised that by registering for this event, Johnson & Johnson will use your Personally Identifiable Information as your confirmation to participate in this WebEx. This information may be shared with Veridex, LLC, its affiliates and a third party vendor for the sole purpose of fulfilling your registration and meeting logistics.
CellSearch is an advanced diagnostic platform commercially available from Veridex, LLC, a Johnson & Johnson company that enables the capture, identification and classification of rare CTCs. CellSearch is available through Molecular Pathology Laboratory Network, Inc. (MPLN) and is FDA-approved to be used as an aid in monitoring metastatic breast, colon and prostate cancers. For more information about CellSearch, call MPLN at 866-726-1833.
